Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

1.

Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J.

Lancet Infect Dis. 2015 Apr 14. pii: S1473-3099(15)70139-8. doi: 10.1016/S1473-3099(15)70139-8. [Epub ahead of print]

PMID:
25886798
2.

Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.

Bellan SE, Dushoff J, Galvani AP, Meyers LA.

PLoS Med. 2015 Mar 17;12(3):e1001801. doi: 10.1371/journal.pmed.1001801. eCollection 2015 Mar.

3.

Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.

Gutfraind A, Galvani AP, Meyers LA.

JAMA Pediatr. 2015 Apr 1;169(4):341-8. doi: 10.1001/jamapediatrics.2014.3804.

PMID:
25706618
4.

Evaluating Large-scale Blood Transfusion Therapy for the Current Ebola Epidemic in Liberia.

Gutfraind A, Meyers LA.

J Infect Dis. 2015 Apr 15;211(8):1262-7. doi: 10.1093/infdis/jiv042. Epub 2015 Jan 29.

PMID:
25635118
5.

Optimizing distribution of pandemic influenza antiviral drugs.

Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA.

Emerg Infect Dis. 2015 Feb;21(2):251-8. doi: 10.3201/eid2102.141024.

6.

Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission.

Scarpino SV, Iamarino A, Wells C, Yamin D, Ndeffo-Mbah M, Wenzel NS, Fox SJ, Nyenswah T, Altice FL, Galvani AP, Meyers LA, Townsend JP.

Clin Infect Dis. 2015 Apr 1;60(7):1079-82. doi: 10.1093/cid/ciu1131. Epub 2014 Dec 15.

PMID:
25516185
7.

Opinion: Mathematical models: a key tool for outbreak response.

Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18095-6. doi: 10.1073/pnas.1421551111. Epub 2014 Dec 10. No abstract available.

8.

Ebola virus vaccine trials: the ethical mandate for a therapeutic safety net.

Bellan SE, Pulliam JR, Dushoff J, Meyers LA.

BMJ. 2014 Dec 10;349:g7518. doi: 10.1136/bmj.g7518. No abstract available.

PMID:
25498325
9.

Ebola control: effect of asymptomatic infection and acquired immunity.

Bellan SE, Pulliam JR, Dushoff J, Meyers LA.

Lancet. 2014 Oct 25;384(9953):1499-500. doi: 10.1016/S0140-6736(14)61839-0. Epub 2014 Oct 15. No abstract available.

PMID:
25390569
10.

Polyploid formation shapes flowering plant diversity.

Scarpino SV, Levin DA, Meyers LA.

Am Nat. 2014 Oct;184(4):456-65. doi: 10.1086/677752. Epub 2014 Aug 18.

PMID:
25226181
11.

Network-based vaccination improves prospects for disease control in wild chimpanzees.

Rushmore J, Caillaud D, Hall RJ, Stumpf RM, Meyers LA, Altizer S.

J R Soc Interface. 2014 Aug 6;11(97):20140349. doi: 10.1098/rsif.2014.0349.

PMID:
24872503
12.

Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy.

Gilbert JA, Meyers LA, Galvani AP, Townsend JP.

Epidemics. 2014 Mar;6:37-45. doi: 10.1016/j.epidem.2013.11.002. Epub 2013 Nov 19.

13.

Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania.

Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP.

Ann Intern Med. 2014 Jan 21;160(2):91-100.

14.

Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP.

PLoS Negl Trop Dis. 2013 Aug 1;7(8):e2346. doi: 10.1371/journal.pntd.0002346. Print 2013.

15.

Dengue dynamics and vaccine cost-effectiveness in Brazil.

Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP.

Vaccine. 2013 Aug 20;31(37):3957-61. doi: 10.1016/j.vaccine.2013.06.036. Epub 2013 Jun 20.

16.

Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty.

Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP.

Vaccine. 2013 Jun 26;31(30):3079-89. doi: 10.1016/j.vaccine.2013.04.052. Epub 2013 May 16.

17.

Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa.

Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7952-7. doi: 10.1073/pnas.1221396110. Epub 2013 Apr 15. Erratum in: Proc Natl Acad Sci U S A. 2013 May 21;110(21):8750.

18.

Epidemiological effects of group size variation in social species.

Caillaud D, Craft ME, Meyers LA.

J R Soc Interface. 2013 Apr 10;10(83):20130206. doi: 10.1098/rsif.2013.0206. Print 2013 Jun 6.

19.

Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains.

Tekle YI, Nielsen KM, Liu J, Pettigrew MM, Meyers LA, Galvani AP, Townsend JP.

PLoS One. 2012;7(12):e50688. doi: 10.1371/journal.pone.0050688. Epub 2012 Dec 5.

20.

Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania.

Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP.

PLoS Negl Trop Dis. 2012;6(8):e1796. doi: 10.1371/journal.pntd.0001796. Epub 2012 Aug 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk